Related Experiment Video
Updated: Jun 2, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Effects on atrial fibrillation in aged hypertensive rats by Ca(2+)-activated K(+) channel inhibition
Jonas G Diness1, Lasse Skibsbye, Thomas Jespersen
1NeuroSearch A/S, Pederstrupvej 93, 2750 Ballerup, Denmark.
Abstract:
We have shown previously that inhibition of small conductance Ca(2+)-activated K(+) (SK) channels is antiarrhythmic in models of acutely induced atrial fibrillation (AF). These models, however, do not take into account that AF derives from a wide range of predisposing factors, the most prevalent being hypertension. In this study we assessed the effects of two different SK channel inhibitors, NS8593 and UCL1684, in aging, spontaneously hypertensive rats to examine their antiarrhythmic properties in a setting of hypertension-induced atrial remodeling. Male spontaneously hypertensive rats and the normotensive Wistar-Kyoto rat strain were divided in 2×3 groups of animals aged 3, 8, and 11 months, respectively. The animals were randomly assigned to treatment with NS8593, UCL1684, or vehicle, and open chest in vivo experiments including burst pacing-induced AF were performed. The aging spontaneously hypertensive rats were more vulnerable to AF induction both by S2 stimulation and burst pacing. Vehicle affected neither the atrial effective refractory period nor AF duration. SK channel inhibition with NS8593 and UCL1684 significantly increased the atrial effective refractory period and decreased AF duration in both the normotensive and hypertensive strains with no decline in efficacy as age increased. In conclusion, SK channel inhibition with NS8593 and UCL1684 possesses antiarrhythmic properties in a rat in vivo model of paroxysmal AF with hypertension-induced atrial remodeling. The present results support the notion that SK channels may offer a promising new therapeutic target in the treatment of AF.
Insights
Inhibition of small conductance Ca(2+)-activated K(+) (SK) channels using NS8593 and UCL1684 demonstrated antiarrhythmic effects in a rat model of atrial fibrillation (AF) with hypertension. These SK channel inhibitors effectively increased the atrial refractory period and reduced AF duration.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Electrophysiology
Background:
- Small conductance Ca(2+)-activated K(+) (SK) channel inhibition shows antiarrhythmic potential in acute atrial fibrillation (AF) models.
- Existing models do not fully represent AF's complexity, particularly the role of hypertension and atrial remodeling.
Purpose of the Study:
- To evaluate the antiarrhythmic efficacy of SK channel inhibitors (NS8593, UCL1684) in aging, spontaneously hypertensive rats with hypertension-induced atrial remodeling.
- To assess the impact of these inhibitors on atrial electrophysiology and AF vulnerability in a relevant preclinical model.
Main Methods:
- Aging spontaneously hypertensive rats and normotensive Wistar-Kyoto rats (3, 8, 11 months) were treated with NS8593, UCL1684, or vehicle.
- Open-chest in vivo experiments included burst pacing to induce AF and measurements of atrial effective refractory period (AERP).
Main Results:
- Aging hypertensive rats exhibited increased vulnerability to AF induction.
- SK channel inhibition with NS8593 and UCL1684 significantly prolonged the AERP and reduced AF duration in both rat strains.
- The antiarrhythmic efficacy of SK channel inhibitors remained consistent across different ages.
Conclusions:
- SK channel inhibition with NS8593 and UCL1684 exhibits significant antiarrhythmic properties in a rat model of paroxysmal AF associated with hypertension-induced atrial remodeling.
- These findings support SK channels as a promising therapeutic target for AF treatment, even in the presence of underlying hypertension.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Pharmacodynamics in Geriatric Patients: Effects of Age
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

